Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AstraZeneca

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

360info

Dow Jones Futures Fall, Crude Dives After Market Rally Runs Into China Wall

Stocks fell from resistance Monday on China news and looming inflation data. Tesla, Twitter and Alibaba were big losers.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

1.1 billion Covid vaccine doses wasted globally, estimates suggest

‘A lot of Covid-19 vaccine wastage has been driven by the deeply unequal global response to this pandemic,’ says global health campaigner

The Independent UK

COVID vaccines and pregnancy: a review of the evidence shows they are safe

COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…

The Conversation

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

ABC News

Stocks To Watch: Baidu, UnitedHealth Lead 5 Near Buy Points

Stocks to watch this coming week include a diverse group in or near buy zones, including Baidu and UnitedHealth.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

ABC News

Ministry signs contract to buy long-acting antibody drug

The Ministry of Public Health on Wednesday signed a procurement agreement with AstraZeneca for 257,500 doses of the long-acting antibody drug Evusheld, which boosts Covid-19 immunity in patients with low immunity levels.

Bangkok Post

Canada to throw out 13.6m AstraZeneca Covid vaccine doses amid lack of demand

Government pledged to donate millions of doses to other countries but they were ‘not accepted’ despite fresh rise in coronavirus cases around the world

The Guardian - AU

Canada throwing away 13.6m doses of AstraZeneca Covid vaccine that nobody wants

Oxford AstraZeneca vaccine fell out of favour amid concerns about rare but potentially fatal blood clots

Wales Online

Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Musk's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5

Reuters

Benzinga

Dow Jones Futures Fall: Don't Feed The Bear Market; BYD Leaves Tesla In The Dust

Don't feed the bear market, prepare for the next bull run. Tesla deliveries fell sharply in Q2 with BYD on tap.

Investors Business Daily

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc's (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents an expansion of the original master supply and development agreement announced between the two companies in September 2020. The manufacture of COVID-19 vaccines at Oxford Biomedica's Oxbox facility, as part of the…

The Guardian - AU

Not just a number: families of five Australian pandemic victims reflect on loss during Covid

As Australia approaches the grim milestone of 10,000 Covid deaths, we look at the people behind the numbers

ABC News

Ian's 34yo daughter Katie died after receiving AstraZeneca's COVID-19 vaccine. He wants to honour her. But he also wants answers

The family of Katie Lees, who died after receiving a COVID-19 vaccine, say an arts fellowship in her name "lifts" them from being stuck in horror and grief, as they wait for clarity on an inquiry into the vaccine rollout.

Investors Business Daily

IBD 50 Stocks To Watch: Is This Drug Company's Stock A Buy?

AstraZeneca is trying to break out of a new base as earnings growth appears to be on the upswing.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Up As Powell Issues This Inflation Warning; Tesla Stock Falls Amid This Move; Apple Pops

The Dow Jones rose despite Fed Chair Jerome Powell issuing an inflation warning. Tesla stock fell amid closure news. Apple stock rose.

Investors Business Daily

Stock Market Can't Get Out Of The Red; This Education Stock Provides Bright Spot

The Nasdaq composite is down 0.5%, while the S&P 500 is down 0.4%. The Russell 2000 is down 1.7%.

Benzinga

AstraZeneca Whale Trades For June 29

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Investors Business Daily

Dow Jones Dips; Donald Trump SPAC Dives On This Move; Apple Stock Whipsaws Amid Wall Street Call

The Dow Jones fell. The Donald Trump SPAC took a dive amid legal woes. Apple stock treaded water after an analyst call.

Investors Business Daily

IBD Screen Of The Day: Global Leaders Highlight These Top Health Care Stocks

GSK announced positive results in a late-stage study on a new Covid-19 vaccine targeted to combat the omicron variant.

Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Guardian - UK

Vaccinologist Sarah Gilbert: ‘We need to be better prepared for a new pandemic’

The woman who co-developed the AstraZeneca vaccine on reassuring doubters, her new book and having a baby penguin named after her

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.